Max is the CEO and Co-Founder of MindTrace, a company he launched during graduate school to transform cutting-edge neuroscience research into real-world, scalable impact for patients. As Principal Investigator on Small Business Innovation Research (SBIR) awards from the National Institutes of Health and the National Science Foundation, he leads pioneering work at the intersection of neuroscience and neurosurgery, focused on improving neurocognitive outcomes for brain surgery patients. Max has been recognized on the Pittsburgh 30 Under 30 list, and MindTrace was named a Digital Health company to watch by CB Insights.